Edward H Myles

CIK 1358219 · COO & CFO · last filed 2025-03-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.08M

Companies

4

Total Filings

41

Lifetime Open-Market Net

-$16.81M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRRK COO & CFO 205,552 $44.18 $9.08M -$16.81M 24 2025-03-12
AMAG PHARMACEUTICALS, INC. (AMAG) Delisted COO & CFO 98,659 $0 12 2020-03-12
Ocata Therapeutics, Inc. (OCAT) Delisted COO & CFO 0 $0 1 2016-02-11
PRESSURE BIOSCIENCES INC (PBIO) Delisted Senior VP of Finance & CFO $0 1 2008-09-29

Recent Filings · Page 2 of 5

41 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-12-08 SRRK Mixed -$315.7K EDGAR
2023-11-03 SRRK Sell (S) −35,007 -$438.0K EDGAR
2023-06-22 SRRK Tax (F) −7,138 -$62.5K EDGAR
2023-02-15 SRRK Grant (A) +63,750 $0 EDGAR
2023-01-19 SRRK Tax (F) −7,043 -$79.5K EDGAR
2022-06-21 SRRK Grant (A) +74,750 $0 EDGAR
2022-02-15 SRRK Grant (A) +57,500 $0 EDGAR
2022-01-19 SRRK Tax (F) −2,178 -$42.4K EDGAR
2021-11-15 SRRK Mixed -$2.75M EDGAR
2021-02-03 SRRK Grant (A) +24,150 $0 EDGAR
Showing 1120 of 41
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.